Research
Koko started as a clinical trial at MIT. We have since published multiple papers in the fields clinical and social psychology, human-computer interaction, and machine learning. Some representative publications are summarized below.
Koko started as a clinical trial at MIT. We have since published multiple papers in the fields clinical and social psychology, human-computer interaction, and machine learning. Some representative publications are summarized below.
Just presenting resources is the first step. Additional work is required to overcome other structural or attitudinal barriers to reaching out. We have developed methods to increase conversion to crisis resources by systematically helping users overcome common barriers and misconceptions. In a randomized controlled trial with Harvard, we showed our methods increased conversion rates by 23%.
Koko has millions of posts and responses from its peer support network. We analyzed linguistic patterns that predicted favorable outcomes.
We created an artificially empathic chatbot using Koko data. We find that, while we can simulate empathic expression to a degree, there may be an upper bound machines can never cross. Unlike humans, they don't have lived experiences and so their efforts to empathize might always ring hollow.
Most looking to get help on Koko go on to help multiple other people. We make it simple and easy. We also find that helping others on Koko has a significant effect on mood regulation and depression symptoms.
We randomly assigned people to use Koko (then called 'Panoply') or a matched control task (expressive writing). We found improvements for both, but the differences were significantly greater for the Koko platform.
We developed methods to increase utilization of crisis resources such as The National Suicide Prevention Lifeline. In a randomized controlled trial with Harvard, we showed our methods increased conversion rates by 23%.
Koko has millions of posts and responses from its peer support network. We analyzed linguistic patterns that predicted favorable outcomes.
We created an artificially empathic chatbot using Koko data. We find that, while we can simulate empathic expression to a degree, there may be an upper bound machines can never cross. Unlike humans, they don't have lived experiences and so their efforts to empathize might always ring hollow.
Most people looking to get help on Koko go on to help multiple other people. We make it simple and easy. We also find that helping others on Koko has a significant effect on mood regulation and depression symptoms.
We randomly assigned people to use Koko (then called 'Panoply') or a matched control task (expressive writing). We found improvements for both, but the differences were significantly greater for the Koko platform across all outcome measures.
All of our services are free. We take user privacy very seriously and we never sell data. We rely on donations to make our impact.
